Bixiye
Hyftor (sirolimus) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 861 - 870 ee natiijooyinka 3606
Bixiye
Long Acting Insulin - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Rapid to Intermediate Acting Insulin - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Rapid to Intermediate Acting Insulin - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2025
Bixiye
Zoryve (roflumilast) - Commercial
Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Bixiye
QP22-23 Provider Press: Q1 2023
Taariikhda uu dhaqangalayo Barnaamijka: Mar 22, 2023
Bixiye
QP23-23 Register for Webinar | Trauma-Informed Care: Poverty and Health-seeking Behaviors | Tuesday, March 28, 5-6:30 pm
Taariikhda uu dhaqangalayo Barnaamijka: Mar 22, 2023
Bixiye
QP24-23 Claim Audits Information Added to Provider Policy and Procedure Manual
Taariikhda uu dhaqangalayo Barnaamijka: Mar 22, 2023
Bixiye
QP25-23 Change to Submission of Pre-Service Appeals for Medicare Advantage Members
Taariikhda uu dhaqangalayo Barnaamijka: Mar 22, 2023